Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Weighing the cell
MIT biological engineers devise a way to measure, for the first time, how single cells accumulate mass.
To starve a tumor
MIT’s Matthew Vander Heiden is part of a new generation of cancer researchers trying to exploit cancer cells’ strange metabolism.
Listening in on single cells
A novel sensor array is the first to detect single molecules produced by living cells.
New and improved RNA interference
Researchers use RNA interference to silence multiple genes at once. The advance, which one expert calls a ‘substantial breakthrough,’ could lead to new treatments for liver diseases.
Explained: RNA interference
Exploiting the recently discovered mechanism could allow biologists to develop disease treatments by shutting down specific genes.
Nanoparticles for gene therapy improve
MIT team’s nanoparticles could become a safer alternative to gene therapy delivered by viruses.
Possible origins of pancreatic cancer revealed
Tumors can arise from different cell types in the pancreas, depending on the circumstances, according to MIT cancer biologists.
Cancer research gets physical
5-year grant from the National Cancer Institute will fund projects by physicists that give a new view of cancer cells.
Protein is linked to lung cancer development
Drugs that inhibit the protein, which normally helps defend cells from infection, could target tumors in certain lung cancer patients.
Two from MIT elected to the Institute of Medicine
Professor of Economics Amy Finkelstein and Tyler Jacks, director of the Koch Institute, join arm of the National Academies of Science.
In Profile: Scott Manalis
His technology to weigh single cells led to an unexpected research focus: figuring out how cancerous cells escape normal growth controls.
Taking aim at aggressive cancer cells
Researchers use novel stem-cell method to discover chemical with potency against breast tumors in mice
Tumor mutations can predict chemo success
Genetic profiling of tumors could have 'immediate impact' on treating cancer, study shows